Benjamin Lang

Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial

Stephan Glund, Joachim Stangier, Michael Schmohl et al. · The Lancet · 2015 · 318 citations

Medicine, Pharmacology, Pharmacotherapy +10

A randomised study in healthy volunteers to investigate the safety, tolerability and pharmacokinetics of idarucizumab, a specific antidote to dabigatran

Viktoria Moschetti, Stephen H. Norris, Joachim Stangier et al. · Thrombosis and Haemostasis · 2015 · 245 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells

Takanori Eguchi, Chiharu Sogawa, Kisho Ono et al. · Cells · 2020 · 91 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study

Stephan Glund, Joachim Stangier, Joanne van Ryn et al. · Clinical Pharmacokinetics · 2016 · 87 citations · Full text

Nursing, Pharmacokinetics, Pharmacology +17

Pustular psoriasis: Molecular pathways and effects of spesolimab in generalized pustular psoriasis

Patrick Baum, Sudha Visvanathan, Sandra Garcet et al. · Journal of Allergy and Clinical Immunology · 2021 · 86 citations · Full text

Medicine, Dermatology, Immunology +16